Pershing Square Up 6% In First Quarter

Apr 4 2013 | 12:44am ET

Pershing Square Capital Management withstood big losses on two of its most prominent investments to post a 6% gain in the first quarter.

The New York-based hedge fund rose 2.5% last month, the New York Post reports.

That Pershing Square enjoyed any gains is impressive, given the dismal performance of its headline investments. Nutritional supplements company Herbalife, which Pershing Square founder William Ackman has called a pyramid scheme and which the hedge fund has a $1 billion short against, saw its shares surge 14% on the quarter. And retailer J.C. Penney, which Pershing Square owns 17% of, dropped 23% during the first three months of 2013.

Pershing Square still has a roughly $240 million paper profit on its Herbalife short, which it took at the end of last year. It has lost approximately twice as much over the life of its Penney investment.

The hedge fund was saved from a first-quarter disaster by holdings such as Canadian Pacific Railways, which rose 28% in the first quarter, and Procter & Gamble, which rose 13.5%.


In Depth

David Yarrow On Growing His Hedge Fund And Shooting The Animals And People Of Africa - As A Photographer

Jul 23 2014 | 6:44am ET

While he’s always been a photographer, recent expeditions to Iceland, Ethiopia...

Lifestyle

Einhorns Busts At WSOP, Finishes In 173rd

Jul 15 2014 | 10:48am ET

Greenlight Capital founder David Einhorn’s World Series of Poker won’t end at...

Guest Contributor

Common Risk Parity Misperceptions

Jul 16 2014 | 11:02am ET

Over the past few years, risk parity has become a component of most investors’...

 

Sponsored Content

    Northern Trust Helps Hedge Funds Navigate Derivatives Regulations

    Jul 8 2014 | 10:48am ET

    The surge in derivatives regulation is among the most complex challenges facing the financial services industry today. Northern Trust’s Joshua Satten recently spoke with FINalternatives to share insights into the challenges presented by new regulation and explore how the industry is responding. Read more…

Publisher's Note